The funding spherical, which is India’s largest fund elevate within the eyecare house, may even present important capital to gasoline the corporate’s growth plans and pave the way in which for an exit for current investor, ADV Companions. The corporate additionally raised Rs270 crore funding from Temasek in 2019.
At round 11:08 AM, Dr Agarwals Eye Hospital was buying and selling at Rs768.45 apiece up by Rs14.05 or 1.86% on the BSE.
Stated Prof. (Dr.) Amar Agarwal, Chairman, Dr. Agarwal’s Group of Eye Hospitals: “We have now had a fantastic journey with our investor, ADV Companions, over the previous 6 years. We’re very excited to associate with TPG Progress and Temasek and look ahead to the following part of development of our firm.
Backing from such world-renowned marquee traders additional strengthens our ideology of offering high quality eyecare to the folks and bringing superior expertise to far-reaching corners of the nation. The brand new investments will probably be used to increase our Indian and worldwide footprint and deploy newest applied sciences for super-specialty eyecare.”
Dr. Agarwal’s Group of Eye Hospitals has been on a development spree throughout the nation, with greater than 60 items added to its community prior to now 5 years alone. It plans to deploy capital to increase the present community of 105 hospitals to over 200 hospitals within the subsequent 3-4 years. The corporate notched a income of over Rs700 crore in FY22.